Management of patients with locally advanced breast cancer
CONCLUSION: From present study it can be concluded that there is significant increase in operability and survival in our small series of locally advanced breast cancer
with sequential anthracyclinedocetaxel tailored Neoadjuvant chemotherapy.
NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the presentation of preliminary results from a single-arm, open-label, Phase II clinical trial evaluating ABRAXANE[R] for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin- bound) in combination with gemcitabine and epirubicin for the treatment of patients with locally advanced breast cancer
The Phase III studies -- 046 and 048 used for the pooled analysis- included patients with metastatic or locally advanced breast cancer
whose disease had been treated with two widely used and approved chemotherapies (anthracycline and taxane).
Phase II study of neoadjuvant gemcitabine, epirubicin, and albumin-bound nab-paclitaxel (GEA) in locally advanced breast cancer
with SPARC tumor assessments (Abstract 603, Poster 14G)
Neoadjuvant chemotherapy with sequential weekly nanoparticle albumin-bound paclitaxel (ABI-007, ABRAXANE) followed by 5-fluorouracil, epirubicin and cyclophosphamide (FEC) in locally advanced breast cancer
(LABC): a phase II trial of the NSABP Foundation Research Group (Poster Number: 3068)
studied serial breast MR tumor volume measurements using CADstream as predictive of length of recurrence-free survival (LRFS) in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer
Stage III: Locally advanced breast cancer
where the tumor is greater than 5 cm across and has spread to the lymph nodes under the arm; or the cancer is extensive in the underarm lymph nodes; or the cancer has spread to lymph nodes near the breastbone or to other tissues near the breast
Duke University has previously reported promising results from a Phase I breast cancer study designed to demonstrate the ability of thermotherapy to enhance the therapeutic activity of non temperature sensitive liposomal encapsulations of doxorubicin plus traditional paclitaxel (Taxol(R)) in the management of locally advanced breast cancer
com/reports/c19291) has announced the addition of Breast Cancer - Changing Treatment Paradigms For Local And Locally Advanced Breast Cancer
to their offering.
Celsion has obtained exclusive rights to an advanced phased array radio frequency (RF) heating system designed specifically for use with chemotherapeutic drugs for the treatment of locally advanced breast cancer